Depletion of dendritic cells enhances susceptibility to cell-free infection of human T cell leukemia virus type 1 in CD11c-diphtheria toxin receptor transgenic mice

Journal of Immunology

Volumn 184, Issue 10, 2010, Pages 5553-5561

  Rahman, Saifur ^a   Manuel, Sharrón L ^a   Khan, Zafar K ^a   Wigdahl, Brian ^a   Acheampong, Edward ^a   Tangy, Frederic ^b   Jain, Pooja ^a  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN P 15095; MESSENGER RNA; TAX PROTEIN; DIPHTHERIA TOXIN; HEPARIN BINDING EPIDERMAL GROWTH FACTOR; HEPARIN-BINDING EGF-LIKE GROWTH FACTOR; SIGNAL PEPTIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; DENDRITIC CELL; ENVELOPE GENE; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS INFECTION; IMMUNOPATHOGENESIS; INFECTION SENSITIVITY; MOLONEY LEUKEMIA ONCOVIRUS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROVIRUS; TRANSGENIC MOUSE; VIRUS LOAD; VIRUS PATHOGENESIS; ANIMAL; C57BL MOUSE; CELL DEATH; CELL FREE SYSTEM; CELL LINE; DISEASE PREDISPOSITION; GENETICS; HUMAN; IMMUNOLOGY; LEUKAPHERESIS; METABOLISM; METHODOLOGY; PATHOLOGY; TROPICAL SPASTIC PARAPARESIS; VIROLOGY;

ANIMALS; ANTIGENS, CD11C; CELL DEATH; CELL LINE; CELL-FREE SYSTEM; DENDRITIC CELLS; DIPHTHERIA TOXIN; DISEASE SUSCEPTIBILITY; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LEUKAPHERESIS; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; PARAPARESIS, TROPICAL SPASTIC;

EID: 77954699493     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0903226     Document Type: Article

References (62)

1. Proietti, F. A., A. B. Carneiro-Proietti, B. C. Catalan-Soares, and E. L. Murphy. 2005. Global epidemiology of HTLV-I infection and associated diseases. Oncogene 24: 6058-6068. (Pubitemid 43086123)
2. Kaplan, J. E., M. Osame, H. Kubota, A. Igata, H. Nishitani, Y. Maeda, R. F. Khabbaz, and R. S. Janssen. 1990. The risk of development of HTLV-Iassociated myelopathy/tropical spastic paraparesis among persons infected with HTLV-I. J. Acquir. Immune Defic. Syndr. 3: 1096-1101.
3. Murphy, E. L., B. Hanchard, J. P. Figueroa, W. N. Gibbs, W. S. Lofters, M. Campbell, J. J. Goedert, and W. A. Blattner. 1989. Modelling the risk of adult T-cell leukemia/lymphoma in persons infected with human T-lymphotropic virus type I. Int. J. Cancer 43: 250-253.
4. Ohshima, K. 2007. Pathological features of diseases associated with human Tcell leukemia virus type I. Cancer Sci. 98: 772-778.
5. Uchiyama, T., J. Yodoi, K. Sagawa, K. Takatsuki, and H. Uchino. 1977. Adult Tcell leukemia: clinical and hematologic features of 16 cases. Blood 50: 481-492.
6. Gessain, A., F. Barin, J. C. Vernant, O. Gout, L. Maurs, A. Calender, and G. de Thé. 1985. Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet 326: 407-410.
7. Osame, M., K. Usuku, S. Izumo, N. Ijichi, H. Amitani, A. Igata, M. Matsumoto, and M. Tara. 1986. HTLV-I associated myelopathy, a new clinical entity. Lancet 327: 1031-1032. (Pubitemid 16102987)
8. Maloney, E. M., F. R. Cleghorn, O. S. Morgan, P. Rodgers-Johnson, B. Cranston, N. Jack, W. A. Blattner, C. Bartholomew, and A. Manns. 1998. Incidence of HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP) in Jamaica and Trinidad. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 17: 167-170.
9. Maguer-Satta, V., L. Gazzolo, and M. D. Dodon. 1995. Human immature thymocytes as target cells of the leukemogenic activity of human T-cell leukemia virus type I. Blood 86: 1444-1452.
10. Osame, M., R. Janssen, H. Kubota, H. Nishitani, A. Igata, S. Nagataki, M. Mori, I. Goto, H. Shimabukuro, R. Khabbaz, et al. 1990. Nationwide survey of HTLVI-associated myelopathy in Japan: association with blood transfusion. Ann. Neurol. 28: 50-56.
11. Ohashi, T., S. Hanabuchi, H. Kato, Y. Koya, F. Takemura, K. Hirokawa, T. Yoshiki, Y. Tanaka, M. Fujii, and M. Kannagi. 1999. Induction of adult T-cell leukemia-like lymphoproliferative disease and its inhibition by adoptive immunotherapy in T-cell-deficient nude rats inoculated with syngeneic human Tcell leukemia virus type 1-immortalized cells. J. Virol. 73: 6031-6040.
12. Kannagi, M., T. Ohashi, S. Hanabuchi, H. Kato, Y. Koya, A. Hasegawa, T. Masuda, and T. Yoshiki. 2000. Immunological aspects of rat models of HTLV type 1-infected T lymphoproliferative disease. AIDS Res. Hum. Retroviruses 16: 1737-1740.
13. Asquith, B., and C. R. Bangham. 2007. Quantifying HTLV-I dynamics. Immunol. Cell Biol. 85: 280-286.
14. Wattel, E., J. P. Vartanian, C. Pannetier, and S. Wain-Hobson. 1995. Clonal expansion of human T-cell leukemia virus type I-infected cells in asymptomatic and symptomatic carriers without malignancy. J. Virol. 69: 2863-2868.
15. Matsuoka, M., and K. T. Jeang. 2007. Human T-cell leukaemia virus type 1 (HTLV-1) infectivity and cellular transformation. Nat. Rev. Cancer 7: 270-280.
16. Igakura, T., J. C. Stinchcombe, P. K. Goon, G. P. Taylor, J. N. Weber, G. M. Griffiths, Y. Tanaka, M. Osame, and C. R. Bangham. 2003. Spread of HTLV-I between lymphocytes by virus-induced polarization of the cytoskeleton. Science 299: 1713-1716. (Pubitemid 36337193)
17. McDonald, D., L. Wu, S. M. Bohks, V. N. KewalRamani, D. Unutmaz, and T. J. Hope. 2003. Recruitment of HIV and its receptors to dendritic cell-T cell junctions. Science 300: 1295-1297.
18. Jolly, C., K. Kashefi, M. Hollinshead, and Q. J. Sattentau. 2004. HIV-1 cell to cell transfer across an Env-induced, actin-dependent synapse. J. Exp. Med. 199: 283-293.
19. Richardson, J. H., A. J. Edwards, J. K. Cruickshank, P. Rudge, and A. G. Dalgleish. 1990. In vivo cellular tropism of human T-cell leukemia virus type 1. J. Virol. 64: 5682-5687.
20. + T lymphocytes naturally infected with human T cell lymphotropic virus type I. Immunity 13: 657-664.
21. + T cells are an in vivo reservoir for human T-cell lymphotropic virus type I. Blood 98: 1858-1861.
22. Grant, C., K. Barmak, T. Alefantis, J. Yao, S. Jacobson, and B. Wigdahl. 2002. Human T cell leukemia virus type I and neurologic disease: events in bone marrow, peripheral blood, and central nervous system during normal immune surveillance and neuroinflammation. J. Cell. Physiol. 190: 133-159.
23. Lehky, T. J., C. H. Fox, S. Koenig, M. C. Levin, N. Flerlage, S. Izumo, E. Sato, C. S. Raine, M. Osame, and S. Jacobson. 1995. Detection of human T-lymphotropic virus type I (HTLV-I) tax RNA in the central nervous system of HTLV-I-associated myelopathy/tropical spastic paraparesis patients by in situ hybridization. Ann. Neurol. 37: 167-175.
24. Watabe, K., T. Saida, and S. U. Kim. 1989. Human and simian glial cells infected by human T-lymphotropic virus type I in culture. J. Neuropathol. Exp. Neurol. 48: 610-619.
25. Yamada, M., K. Watabe, T. Saida, and S. U. Kim. 1991. Increased susceptibility of human fetal astrocytes to human T-lymphotropic virus type I in culture. J. Neuropathol. Exp. Neurol. 50: 97-107.
26. Hoffman, P. M., S. Dhib-Jalbut, J. A. Mikovits, D. S. Robbins, A. L. Wolf, G. K. Bergey, N. C. Lohrey, O. S. Weislow, and F. W. Ruscetti. 1992. Human Tcell leukemia virus type I infection of monocytes and microglial cells in primary human cultures. Proc. Natl. Acad. Sci. USA 89: 11784-11788.
27. Kasai, T., H. Ikeda, U. Tomaru, I. Yamashita, O. Ohya, K. Morita, A. Wakisaka, E. Matsuoka, T. Moritoyo, K. Hashimoto, et al. 1999. A rat model of human T lymphocyte virus type I (HTLV-I) infection: in situ detection of HTLV-I provirus DNA in microglia/macrophages in affected spinal cords of rats with HTLV-Iinduced chronic progressive myeloneuropathy. Acta Neuropathol. 97: 107-112.
28. Ali, A., S. Patterson, K. Cruickshank, P. Rudge, A. G. Dalgleish, and S. C. Knight. 1993. Dendritic cells infected in vitro with human T cell leukaemia/lymphoma virus type-1 (HTLV-1); enhanced lymphocytic proliferation and tropical spastic paraparesis. Clin. Exp. Immunol. 94: 32-37.
29. Makino, M., S. Wakamatsu, S. Shimokubo, N. Arima, and M. Baba. 2000. Production of functionally deficient dendritic cells from HTLV-I-infected monocytes: implications for the dendritic cell defect in adult T cell leukemia. Virology 274: 140-148. (Pubitemid 30650689)
30. Makino, M., A. Utsunomiya, Y. Maeda, S. Shimokubo, S. Izumo, and M. Baba. 2001. Association of CD40 ligand expression on HTLV-I-infected T cells and maturation of dendritic cells. Scand. J. Immunol. 54: 574-581.
31. Hishizawa, M., K. Imada, T. Kitawaki, M. Ueda, N. Kadowaki, and T. Uchiyama. 2004. Depletion and impaired interferon-alpha-producing capacity of blood plasmacytoid dendritic cells in human T-cell leukaemia virus type I-infected individuals. Br. J. Haematol. 125: 568-575.
32. Macatonia, S. E., J. K. Cruickshank, P. Rudge, and S. C. Knight. 1992. Dendritic cells from patients with tropical spastic paraparesis are infected with HTLV-1 and stimulate autologous lymphocyte proliferation. AIDS Res. Hum. Retroviruses 8: 1699-1706.
33. + T cells. Nat. Med. 14: 429-436.
34. Manuel, S. L., T. D. Schell, E. Acheampong, S. Rahman, Z. K. Khan, and P. Jain. 2009. Presentation of human T cell leukemia virus type 1 (HTLV-1) Tax protein by dendritic cells: the underlying mechanism of HTLV-1-associated neuroinflammatory disease. J. Leukoc. Biol. 86: 1205-1216.
35. Makino, M., S. Shimokubo, S. I. Wakamatsu, S. Izumo, and M. Baba. 1999. The role of human T-lymphotropic virus type 1 (HTLV-1)-infected dendritic cells in the development of HTLV-1-associated myelopathy/tropical spastic paraparesis. J. Virol. 73: 4575-4581. (Pubitemid 29246715)
36. Kampani, K., K. Quann, J. Ahuja, B. Wigdahl, Z. K. Khan, and P. Jain. 2007. A novel high throughput quantum dot-based fluorescence assay for quantitation of virus binding and attachment. J. Virol. Methods 141: 125-132.
37. Jain, P., S. L. Manuel, Z. K. Khan, J. Ahuja, K. Quann, and B. Wigdahl. 2009. DC-SIGN mediates cell-free infection and transmission of human T-cell lymphotropic virus type 1 by dendritic cells. J. Virol. 83: 10908-10921.
38. + cytotoxic T lymphocytes specific for HTLV-I pX in patients with HTLV-I associated neurological disease. Nature 348: 245-248.
39. Mostoller, K., C. C. Norbury, P. Jain, and B. Wigdahl. 2004. Human T-cell leukemia virus type I Tax induces the expression of dendritic cell markers associated with maturation and activation. J. Neurovirol. 10: 358-371. (Pubitemid 40109623)
40. Ahuja, J., K. Kampani, S. Datta, B. Wigdahl, K. E. Flaig, and P. Jain. 2006. Use of human antigen presenting cell gene array profiling to examine the effect of human T-cell leukemia virus type 1 Tax on primary human dendritic cells. J. Neurovirol. 12: 47-59.
41. Ahuja, J., V. Lepoutre, B. Wigdahl, Z. K. Khan, and P. Jain. 2007. Induction of pro-inflammatory cytokines by human T-cell leukemia virus type-1 Tax protein as determined by multiplexed cytokine protein array analyses of human dendritic cells. Biomed Pharmacother. 61: 201-208.
42. Jain, P., J. Ahuja, Z. K. Khan, S. Shimizu, O. Meucci, S. R. Jennings, and B. Wigdahl. 2007. Modulation of dendritic cell maturation and function by the Tax protein of human T cell leukemia virus type 1. J. Leukoc. Biol. 82: 44-56.
43. Delebecque, F., K. Pramberger, M. C. Prévost, M. Brahic, and F. Tangy. 2002. A chimeric human T-cell lymphotropic virus type 1 with the envelope glycoprotein of Moloney murine leukemia virus is infectious for murine cells. J. Virol. 76: 7883-7889.
44. Delebecque, F., C. Combredet, A. S. Gabet, E. Wattel, M. Brahic, and F. Tangy. 2005. A chimeric human T cell leukemia virus type I bearing a deltaR Moloneymurine leukemia virus envelope infects mice persistently and induces humoral and cellular immune responses. J. Infect. Dis. 191: 255-263.
45. Potash, M. J., W. Chao, G. Bentsman, N. Paris, M. Saini, J. Nitkiewicz, P. Belem, L. Sharer, A. I. Brooks, and D. J. Volsky. 2005. A mouse model for study of systemic HIV-1 infection, antiviral immune responses, and neuroinvasiveness. Proc. Natl. Acad. Sci. USA 102: 3760-3765.
46. + T cells by exogenous cell-associated antigens. Immunity 17: 211-220.
47. + T cells, and disease severity in HTLV-1-associated myelopathy (HAM/TSP). Blood 99: 88-94.
48. Livak, K. J., and T. D. Schmittgen. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25: 402-408. (Pubitemid 34164012)
49. + T cells in vivo. J. Immunol. 154: 5684-5693.
50. + T cells following an acute virus infection. Eur. J. Immunol. 33: 2736-2743.
51. Probst, H. C., and M. van den Broek. 2005. Priming of CTLs by lymphocytic choriomeningitis virus depends on dendritic cells. J. Immunol. 174: 3920-3924.
52. Kassim, S. H., N. K. Rajasagi, X. Zhao, R. Chervenak, and S. R. Jennings. 2006. In vivo ablation of CD11c-positive dendritic cells increases susceptibility to herpes simplex virus type 1 infection and diminishes NK and T-cell responses. J. Virol. 80: 3985-3993.
53. Knight, S. C., S. E. Macatonia, K. Cruickshank, P. Rudge, and S. Patterson. 1993. Dendritic cells in HIV-1 andHTLV-1 infection. Adv. Exp. Med. Biol. 329: 545-549.
54. Fang, J., S. Kushida, R. Feng, M. Tanaka, T. Kawamura, H. Abe, N. Maeda, M. Onobori, M. Hori, K. Uchida, and M. Miwa. 1998. Transmission of human Tcell leukemia virus type 1 to mice. J. Virol. 72: 3952-3957.
55. Feng, R., M. Tanaka, H. Abe, N. Arashi, B. Sun, K. Uchida, and M. Miwa. 1999. Human T-cell leukemia virus type 1 can infect a wide variety of cells in mice. Jpn. J. Cancer Res. 90: 48-54.
56. Kushida, S., N. Maeda, J. Fang, K. Uchida, and M. Miwa. 1997. Establishment of HTLV-1 carrier mice by injection with HTLV-1-producing T cells. Leukemia 11(Suppl 3): 260-262. (Pubitemid 27313503)
57. Denesvre, C., P. Sonigo, A. Corbin, H. Ellerbrok, and M. Sitbon. 1995. Influence of transmembrane domains on the fusogenic abilities of human and murine leukemia retrovirus envelopes. J. Virol. 69: 4149-4157.
58. Li, Q. X., D. Camerini, Y. Xie, M. Greenwald, D. R. Kuritzkes, and I. S. Chen. 1996. Syncytium formation by recombinant HTLV-II envelope glycoprotein. Virology 218: 279-284.
59. Nagy, K., P. Clapham, R. Cheingsong-Popov, and R. A. Weiss. 1983. Human Tcell leukemia virus type I: induction of syncytia and inhibition by patients' sera. Int. J. Cancer 32: 321-328. (Pubitemid 13050651)
60. Sommerfelt, M. A., B. P. Williams, P. R. Clapham, E. Solomon, P. N. Goodfellow, and R. A. Weiss. 1988. Human T cell leukemia viruses use a receptor determined by human chromosome 17. Science 242: 1557-1559.
61. Bennett, C. L., and B. E. Clausen. 2007. DC ablation in mice: promises, pitfalls, and challenges. Trends Immunol. 28: 525-531.
62. Tateno, M. 1987. [Rat lymphoid cell lines producing human T cell leukemia virus-I]. Hokkaido Igaku Zasshi 62: 74-81.